304 related articles for article (PubMed ID: 20535130)
1. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma.
De Giorgi V; Pinzani P; Salvianti F; Panelos J; Paglierani M; Janowska A; Grazzini M; Wechsler J; Orlando C; Santucci M; Lotti T; Pazzagli M; Massi D
J Invest Dermatol; 2010 Oct; 130(10):2440-7. PubMed ID: 20535130
[TBL] [Abstract][Full Text] [Related]
2. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
3. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
4. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.
Farthmann B; Eberle J; Krasagakis K; Gstöttner M; Wang N; Bisson S; Orfanos CE
J Invest Dermatol; 1998 Mar; 110(3):263-7. PubMed ID: 9506446
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
Ghossein RA; Carusone L; Bhattacharya S
In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Thiel E; Foerster MH; Keilholz U
Oncology; 2011; 80(1-2):57-62. PubMed ID: 21625180
[TBL] [Abstract][Full Text] [Related]
7. Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis.
De Giorgi V; Pinzani P; Salvianti F; Grazzini M; Orlando C; Lotti T; Pazzagli M; Massi D
Arch Dermatol; 2010 Oct; 146(10):1120-4. PubMed ID: 20956643
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
9. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
11. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
12. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
Kiyohara E; Hata K; Lam S; Hoon DS
Methods Mol Biol; 2014; 1102():513-22. PubMed ID: 24258996
[TBL] [Abstract][Full Text] [Related]
14. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
Quereux G; Denis M; Khammari A; Lustenberger P; Dreno B
Dermatology; 2001; 203(3):221-5. PubMed ID: 11701975
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the RT-PCR technique to detect melanoma cells in peripheral blood.
Suárez A; Fra J; Alonso R; Sánchez R; Lacave AJ; Gutiérrez C
Anticancer Res; 2002; 22(2B):1091-5. PubMed ID: 12168906
[TBL] [Abstract][Full Text] [Related]
17. Tumour microdissemination and survival in metastatic melanoma.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Franzke A; Sel S; Atzpodien E; Buer J
Anticancer Res; 2000; 20(5B):3619-24. PubMed ID: 11131671
[TBL] [Abstract][Full Text] [Related]
18. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U
Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
Tsao H; Nadiminti U; Sober AJ; Bigby M
Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
[TBL] [Abstract][Full Text] [Related]
20. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]